Imatinib mesylate for gastrointestinal stromal tumours (GISTs)

  • Withdrawn
  • Protocol
  • Intervention

Authors


Karin L Dearness, Department of Medicine, McMaster University, 1200 Main Street West, HSC 3N51C, Hamilton, Ontario, L8N 3Z5, Canada. dearnes@mcmaster.ca.

Reason for withdrawal from publication

The protocol was withdrawn in August 2012 due to lack of progress. The protocol had previously been withdrawn in April 2011 and registered by a new review team.